Approaches to Clinical Management for Patients with Ebola Treated in U.S. Hospitals

Date:Monday, October 20, 2014

Time:2:00 – 3:30 PM (Eastern Time)

Presenter(s)

Overview

The 2014 Ebola epidemic is the largest in history, affecting multiple countries in West Africa. A small number of patients with Ebola virus disease (EVD) have been medically evacuated from West Africa to receive care in U.S. hospitals. The first imported case of Ebola was diagnosed in the United States in a person who had traveled from West Africa to Dallas, Texas and two secondary Ebola cases in health care workers have been identified as of October 14, 2014. CDC and our partners are taking precautions to prevent the spread of Ebola by sharing information with clinicians who may provide care for patients with EVD. During this COCA Call, clinicians will learn the clinical features and complications associated with Ebola and recommendations from Emory University Hospital and the University of Nebraska Medical Center on clinical management of patients with EVD.

Call Materials

• Audio: Listen Now
• Transcript: Read Now
• Slides: There are no PowerPoint slides for this call.

Additional Resources

• CDC Ebola Virus Disease: Information for Healthcare Workers
• HHS Detailed Hospital Checklist for Ebola Preparedness
• CDC Review of Human-to-Human Transmission of Ebola Virus
• University of Nebraska Medical Center Ebola Patients Donning Biological PPE Resource
• University of Nebraska Medical Center Ebola Patients Doffing Biological PPE Resource
• Emory Healthcare Ebola Preparedness Protocols

Call Format

• Audio conference call on 10/20/14: 2:00 - 3:30 PM
• Web-on-demand training after 3:30 PM on 10/21/14

Accreditation Statements

Accreditation Statements

CME:The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME^®) to provide continuing medical education for physicians.

The Centers for Disease Control and Prevention designates this live activity for a maximum of 0.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CNE:The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center's Commission on Accreditation.

This activity provides 0.0 contact hour.

IACET CEU:The CDC has been approved as an Authorized Provider by the International Association for Continuing Education and Training (IACET), 1760 Old Meadow Road, Suite 500, McLean, VA 22102. The CDC is authorized by IACET to offer 0.0 ANSI/IACET CEU's for this program.

CECH:Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to total 0 Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number GA0082.

CPE:The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is a designated event for pharmacists to receive 0.0 Contact Hour in pharmacy education. The Universal Activity Number is 0387-0000-14-166-L04-P and enduring 0387-0000-14-166-H04-P course category.

This program is knowledge based.

AAVSB/RACE:This program was reviewed and approved by the AAVSB RACE program for 0.0 hours of continuing education in the jurisdictions which recognize AAVSB RACE approval. Please contact the AAVSB RACE Program at race@aavsb.org if you have any comments/concerns regarding this program’s validity or relevancy to the veterinary profession.

DISCLOSURE:In compliance with continuing education requirements, CDC, our planners, our presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias.

The presentation will not include any discussion of the unlabeled use of a product or a product under investigational use.

CDC does not accept commercial support.